Research and Markets: Seroquel - Analysis and Estimates from 2002 to 2020 - The Report Includes Information on the Schizop

DUBLIN--(BUSINESS WIRE)-- Research and Markets(http://www.researchandmarkets.com/research/f0a6ca/seroquel_analysi) has announced the addition of GlobalData's new report "Seroquel - Analysis and Estimates from 2002 to 2020" to their offering.

GlobalData's pharmaceuticals report, Seroquel - Analysis and Estimates from 2002 to 2020 provides Seroquel sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope:

  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
  • Analysis and review of Seroquel including historical sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Seroquel including efficacy, safety, pricing and other details which influence its sales potential
  • Detailed sales forecast for 2011-2020 for Seroquel in each of the seven major markets

Reasons to Buy:

  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drug's performance
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

Key Topics Covered:

1 List of tables and figures 2 Introduction 3 Schizophrenia: Market Characterization 4 Classification of Schizophrenia 5 Treatment for Schizophrenia 6 Seroquel 7 Schizophrenia Market: Appendix

For more information visit http://www.researchandmarkets.com/research/f0a6ca/seroquel_analysi



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

With momentum building in Pfizer’s gene therapy programs, it has bought a building in North Carolina where it will consolidate clinical manufacturing.

Novo Nordisk had been hoping to show its Tresiba could top Sanofi’s Toujeo in a head-to-head showdown, but it didn't quite get there.

GlaxoSmithKline won an FDA panel recommendation for its over-the-counter nicotine spray—but the backing didn’t come easy.